Nivedita Patni1, Crésio Alves1, Julia von Schnurbein1, Martin Wabitsch1, Grace Tannin1, Dinesh Rakheja1, Abhimanyu Garg1. 1. Division of Pediatric Endocrinology (N.P., G.T.), Department of Pediatrics, UT Southwestern Medical Center, Dallas, Texas 75390; Hospital Universitario Prof. Edgard Santos (C.A.), Pediatric Endocrinology Unit, Faculty of Medicine Federal University of Bahia, 401157-190 Salvador, Bahia, Brazil; Division of Pediatric Endocrinology and Diabetes (J.v.S., M.W.), Department of Pediatrics and Adolescent Medicine, University of Ulm, 89075 Ulm, Germany; and Departments of Pathology and Pediatrics (D.R.), and Division of Nutrition and Metabolic Diseases, Department of Internal Medicine (A.G.), UT Southwestern Medical Center, Dallas, Texas 75390.
Abstract
CONTEXT: A rare presentation of hypothalamic tumors in infants and young children is profound emaciation and generalized loss of sc adipose tissue, also known as "diencephalic syndrome." Similar loss of sc fat can be observed in children with acquired generalized lipodystrophy or congenital generalized lipodystrophy. Precise diagnosis may be challenging early in the course of the disease, especially in the absence of metabolic abnormalities. CASE DESCRIPTION: We report three males who presented with poor weight gain and generalized loss of sc fat at birth to 3 years of age consistent with generalized lipodystrophy, with subsequent development of pilocytic astrocytoma. Two of them had hypothalamic tumors, and one had a multicentric tumor with a large right parietal mass. Our patients are unique because the onset of lipodystrophy occurred 2.5 to 7.3 years before the diagnosis of brain tumor, and all of them gained body fat or weight after surgical removal and/or chemotherapy. One patient had hepatosplenomegaly and impaired glucose tolerance, and another patient had severe hyperglycemia and hypertriglyceridemia during the course of the disease. Two patients presented with central precocious puberty and advanced bone age at the chronological age of 6 years. CONCLUSIONS: It is likely that pilocytic astrocytoma may induce generalized lipodystrophy by paraneoplastic antiadipocyte antibody formation or by excessive hormones or cytokine secretion resulting in excess lipolysis from adipocytes. We conclude that young children presenting with idiopathic acquired generalized lipodystrophy or atypical congenital generalized lipodystrophy, with or without metabolic abnormalities, should prompt investigation for brain tumors.
CONTEXT: A rare presentation of hypothalamic tumors in infants and young children is profound emaciation and generalized loss of sc adipose tissue, also known as "diencephalic syndrome." Similar loss of sc fat can be observed in children with acquired generalized lipodystrophy or congenital generalized lipodystrophy. Precise diagnosis may be challenging early in the course of the disease, especially in the absence of metabolic abnormalities. CASE DESCRIPTION: We report three males who presented with poor weight gain and generalized loss of sc fat at birth to 3 years of age consistent with generalized lipodystrophy, with subsequent development of pilocytic astrocytoma. Two of them had hypothalamic tumors, and one had a multicentric tumor with a large right parietal mass. Our patients are unique because the onset of lipodystrophy occurred 2.5 to 7.3 years before the diagnosis of brain tumor, and all of them gained body fat or weight after surgical removal and/or chemotherapy. One patient had hepatosplenomegaly and impaired glucose tolerance, and another patient had severe hyperglycemia and hypertriglyceridemia during the course of the disease. Two patients presented with central precocious puberty and advanced bone age at the chronological age of 6 years. CONCLUSIONS: It is likely that pilocytic astrocytoma may induce generalized lipodystrophy by paraneoplastic antiadipocyte antibody formation or by excessive hormones or cytokine secretion resulting in excess lipolysis from adipocytes. We conclude that young children presenting with idiopathic acquired generalized lipodystrophy or atypical congenital generalized lipodystrophy, with or without metabolic abnormalities, should prompt investigation for brain tumors.
Authors: T Y Poussaint; P D Barnes; K Nichols; D C Anthony; L Cohen; N J Tarbell; L Goumnerova Journal: AJNR Am J Neuroradiol Date: 1997-09 Impact factor: 3.825
Authors: Amy Fleischman; Catherine Brue; Tina Young Poussaint; Mark Kieran; Scott L Pomeroy; Liliana Goumnerova; R Michael Scott; Laurie E Cohen Journal: Pediatrics Date: 2005-06 Impact factor: 7.124
Authors: J C Benson; J Trejo-Lopez; S E Bach; J Schwartz; T J Kaufmann; L Eckel; J Guerin Journal: AJNR Am J Neuroradiol Date: 2021-05-06 Impact factor: 4.966
Authors: Fernando Corvillo; Verónica Aparicio; Alberto López-Lera; Sofía Garrido; David Araújo-Vilar; María P de Miguel; Margarita López-Trascasa Journal: Front Immunol Date: 2018-09-19 Impact factor: 7.561